Stocks
CONMED (CNMD) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 311.0% | 293.1% | 216.4% | 276.4% | 397.7% | ||||
| Changes by years, y/y, % | +84pp | -18pp | -77pp | -216pp | +1.6% | ||||
CONMED. R&D/CAPEX, %
CONMED. R&D/CAPEX, changes, pp
CONMED (CNMD) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 288.9% | 668.0% | 392.7% | 396.5% | 397.7% | |||
| Changes by years, y/y, % | -215pp | +74pp | +373pp | +93pp | +165pp | |||
| Changes by quarters, q/q, % | -231pp | +379pp | -275pp | +4pp | ||||
